Yahoo Web Search

Search results

    • Why Wall Street Is Chasing Ozempic Wannabes

      Why Wall Street Is Chasing Ozempic Wannabes

      The Wall Street Journal· 2 days ago

      But for now, the market is assigning most of the value from the obesity trade to Eli Lilly and Novo because of their manufacturing moat and strong...